Skin substitutes and dermal matrix in scar reconstruction

Overview

Burn scar reconstruction exists because the deep burn wound never quite closes the loop. Deep dermal and full-thickness burns produce scar sequelae (contracture, hypertrophy, pain, and itching) even when the acute coverage went well ^[1][11]. Hypertrophic scarring affects roughly three quarters of major-thermal-burn-injury survivors, and over half experience chronic pain or itch ^[11]. The reconstructive surgeon meets the patient months to years later: scar contracture across a joint, exposed bone or tendon under unstable scar, hypertrophic plaque pulling at facial features, or a tight neck that limits extension. Skin substitutes and dermal matrix products are the reconstructive workhorse for these problems when scar excision and replacement of dermis is the right operation.

The reconstruction-phase use of these products is distinct from acute coverage. In the acute phase, dermal substitutes temporize until autograft is available or contribute a regenerated dermal layer that supports a thinner autograft and a better scar ^[1][8][19]. In reconstruction, the wound is created surgically (by scar excision, contracture release, or excision of hypertrophic plaque), and the reconstructive question is what to put under and over the resulting defect. The clinical anchor is wound depth: a full-thickness defect after scar release needs a dermal layer if the goal is a stable, pliable, mobile cover ^[1]. Dermal regenerative matrices improve scar quality (Vancouver Scar Scale across eight studies) and range of motion (95% of reconstructive patients with described changes) in burn reconstruction ^[23].

The product universe overlaps with acute-phase use: Integra dermal regeneration template, MatriDerm collagen-elastin matrix, AlloDerm acellular human dermis, NovoSorb BTM synthetic polyurethane matrix, and cultured cellular products such as cultured epidermal autograft and autologous skin cell suspension. The reconstructive-phase evidence is most robust for Integra in hand reconstruction ^[21] and for hypertrophic scar excision and replacement ^[8]. The systematic review of dermal regenerative matrices in burn patients found that across 1,084 patients (74% acute, 26% reconstruction), 95% of reconstructive patients showed significant improvement in range of motion, with significant Vancouver Scar Scale improvement on eight studies ^[23]. The collective signal points the same direction: dermal substitution improves scar quality and joint function in reconstruction, with a 13% complication rate concentrated in infection, graft loss, hematoma, and recurrent contracture ^[23].

Pathophysiology

Dermal substitutes act on burn scar through three mechanisms: replacement of missing dermis with a collagen-based template that supports neodermal formation, modulation of contracture through altered collagen organization, and donor-site economy through cultured cellular products that extend epidermal coverage from minimal autograft. The unifying principle is that scar quality improves when a regenerated dermal layer separates the epidermis from the contractile wound bed.

Integra dermal matrix was introduced in 1981 with established use in acute surgical burns; the Integra neodermis is placed at the time of scar excision and overgrafted several weeks later with a very thin (6/1000-inch) skin graft ^[8]. The integration is reliable: in the postapproval multicenter cohort of 216 burn patients, mean Integra take rate was 76.2% with median 95% ^[19]. Complete vascularization of Integra occurs later than for biosynthetic alternatives such as cellulose sponge, which is expected from the longer dermal-template integration window ^[9]. MatriDerm is the single-layer alternative, a 1 or 2 mm bovine collagen matrix supplemented with elastin hydrolysate that may be covered in a single-step procedure with immediate split-thickness skin grafting; in experimental models the matrix reduces wound contracture, with collagen bundles in the resulting scar more randomly oriented ^[26].

In the AlloDerm pilot trial in pediatric burn patients with limited donor sites, study sites grafted with acellular allogeneic dermis plus thin autograft (mean 0.0074 inch) achieved 83% successful initial epithelialization at 7 days postburn, identical to the 83.3% control sites with autograft alone, and Vancouver scar score components did not differ between sites ^[30]. NovoSorb BTM is a synthetic polyurethane temporising matrix that integrates similarly to a dermal scaffold; in 27 patients with 35 wounds, 33 had 100% integration of BTM at the time of sealing membrane removal, demonstrating that synthetic matrices can substitute for biological collagen in selected reconstructive applications ^[25].

Cultured cellular products replace cells rather than scaffold. Cultured epidermal autograft (CEA) is considered for patients with greater than 30% TBSA burns because of the potential for partial-thickness burns to convert to deeper depth over hospitalization time ^[15]. Autologous skin cell suspension (ASCS, ReCell) is a clinically effective and safe approach to reduce the donor skin required for definitive closure of full-thickness defects ^[3][33]. The pathophysiologic rationale is donor-site economy: ReCell donor area is approximately 40 times smaller than a control split-thickness donor site, with significantly faster donor-site healing ^[36].

Classification

Skin replacement products used in burn scar reconstruction fall into four functional classes. Boundaries are not rigid (composite products combine features), but the functional classification organizes clinical reasoning at the operative table.

Acellular dermal matrices (ADM) and dermal regeneration templates. Integra (bilayer collagen-glycosaminoglycan + silicone, two-stage), MatriDerm (single-layer collagen-elastin, one-stage capable), AlloDerm (acellular human dermis), NovoSorb BTM (synthetic polyurethane), and xenogeneic ADM products. In the systematic review of 190 studies on dermal substitutes for acute burns and reconstruction, depth of the wound was the primary indication, with one-stage approaches for deep dermal to full-thickness wounds larger than 10 cm² and two-stage approaches for the same depth wounds with limited donor sites or exposed bone or tendon ^[1]. The xenogeneic ADM meta-analysis pooling 1,596 burn patients across 16 studies showed shorter wound healing time (standardized mean difference −2.50) and lower Vancouver Scar Scale scores (SMD −3.10) than controls, with reduced ratios of scar hyperplasia, complications, and skin grafting ^[10].

Autologous skin grafts. Split-thickness skin grafts (STSG) and full-thickness skin grafts (FTSG) remain the closure of definitive choice for excised burn wounds and for the resurfacing component of contracture release. The choice between STSG and FTSG turns on the trade between donor-site morbidity and scar contracture: in the meta-analysis of 532 pediatric hand burn grafts across 10 non-randomized trials, FTSG produced a statistically significant decrease in post-graft contracture (OR 0.35, P = 0.0001) and later surgical releases (OR 0.06, P = 0.00001) compared with STSG, with better postoperative functional ability, though STSG was superior on scar appearance, color, and hair growth ^[12]. In the systematic review of pediatric volar palmar burns, STSG yielded poorer functional outcomes than FTSG on combined range-of-motion evaluation, though no study has shown FTSG to be significantly superior to STSG on all outcome dimensions ^[34].

Cultured cellular products. Cultured epidermal autograft (CEA, marketed as Epicel) and autologous skin cell suspension (ASCS, ReCell). In the 5-year multicenter retrospective review of 40 patients with mean TBSA 56% treated with CEA on posterior burns, the engraftment rate was 83% with overall survival of 90% ^[15]. Patients with greater than 30% TBSA burns are considered for CEA because superficial partial-thickness burns can convert to deep partial-thickness or full-thickness burns over hospitalization time ^[15]. ASCS combined with widely meshed autograft achieved noninferior 8-week closure (65% versus 58%) versus standard meshed autograft, while requiring 27.4% less donor skin ^[3]. ReCell compared with split-thickness skin grafting in deep partial-thickness burns produced a donor area approximately 40 times smaller than control with significantly faster donor-site healing ^[36].

Flap reconstruction. Local random flaps, perforator-based interposition flaps, pedicled myocutaneous flaps (e.g., extended lower trapezius), free flaps including the gracilis muscle flap and circumflex scapular flap, and tissue-expanded flaps for face and neck. In a multicenter randomized controlled trial of perforator-based interposition flaps versus full-thickness skin grafts for burn scar contracture release, mean scar surface area at 12 months was 142% with flaps versus 92% with FTSG (P < 0.001), with superior POSAS observer score and color ^[28]. Flap reconstruction is the right answer when the released defect needs vascularized tissue, when grafting onto a contracted bed will recur, or when functional restoration of the area requires a soft, well-vascularized cover, particularly in face, neck, hand, and over exposed structures ^[28][31][40].

Assessment

Selection of a reconstructive technique starts with the same three questions that drive any burn-wound decision (depth, size, and trajectory), modified for the post-burn reconstruction phase by the additional questions of joint function, scar quality, and donor reserve. Wound depth is the primary indication for a dermal substitute, with a one-stage approach recommended for deep dermal to full-thickness wounds larger than 10 cm² and a two-stage approach for the same depth wounds with limited donor sites or exposed bone or tendon ^[1]. Superficial scar revision can be managed with excision and primary closure or local flap rearrangement; deeper scar excision exposing fat, fascia, or unstable tissue requires a dermal substitute or vascularized flap.

Joint function and contracture severity drive the second decision. The reconstructive surgeon assesses range of motion, contracture morphology, and functional deficit before operative planning. In the multicenter cohort of 106 patients with cervical burn scar contracture, lateral flexion was the most common limited plane of motion (29.4%); the most severely limited was extension (24.6%); and 72.1% of patients had contractures in 3 to 4 planes of motion ^[41]. Neck skin grafting was an independent risk factor for contracture formation, and cervical and cervicothoracic skin grafting were independent risk factors for severity ^[41]. The findings argue for early identification of high-risk patients and proactive reconstruction. Lateral cervical contractures specifically are divided anatomically into edge and medial types based on whether the scar deficiency is at the edge or center of the trapezoidal scar sheet, and the trapeze-flap plasty is the technique that allows maximum local-tissue use and ensures full contracture elimination for both types ^[39].

Donor-site reserve drives the third decision. In small reconstructive defects, autograft is sufficient. In patients with limited donor sites (extensive burn distribution, repeat reconstructive operations, fragile skin in the elderly), cultured products and ASCS extend donor reserve. CEA is considered for patients with greater than 30% TBSA burns due to the potential for conversion of partial-thickness burns to deeper depth over hospitalization time ^[15].

Trajectory matters because dermal substitutes require a viable wound bed. Contraindications to dermal substitute use include established wound infection and allergy to matrix components ^[1]. The bed must be excised to viable tissue, hemostasis must be adequate, and the fixation and dressing must address fluid collection, mechanical disruption, and infection during the integration window. Limited data exist on dermal-substitute use in patients with diabetes mellitus, chronic vascular disease, or immunocompromised status; careful consideration is advised in electrical and chemical burns ^[1].

Management

Dermal substitute use in scar reconstruction

Integra in burn-scar reconstruction is the prototype dermal-template application. The Integra neodermis is placed at the time of scar excision and overgrafted several weeks later with a very thin (6/1000-inch) skin graft ^[8]. Integra has been useful in the surgical treatment of scars; the stabilized matrix appears to resist recurrence better than traditional skin grafts, which have a reported recurrence rate of 59% ^[8]. In the 14-patient series treating 17 burned hands, 11 in acute phase and 9 in scar reconstruction phase, range of articular motion was complete in 15 of 17 hands, flexible skin coverage was achieved in 88%, the 400 Point Evaluation score averaged 92.8% (range 80 to 100), and 79% of patients returned to normal active working activities ^[21]. Integra in burn reconstruction earns its clinical role through long-term scar pliability, range of motion, and stable cover; the scar-revision-with-FTSG-alone alternative does not consistently match these outcomes.

The Integra-versus-MatriDerm comparison in 12 patients per template treated for burn scar contracture release showed both produced improvement in mobility and skin quality, with the bilayer Integra showing the best performance in retraction rate, skin quality, and mobility recovery, with negative-pressure therapy applied after surgery ^[9]. The double-layer template was not absorbed up to 12 months after placement ^[9]. The single-layer-versus-bilayer choice turns on wound bed quality, donor availability for the second-stage epidermal autograft, and the surgeon's experience with each technique. The collagen-elastin matrix with immediate split-thickness skin grafting is feasible in one stage, with only marginally prolonged healing time compared with autograft alone, no diminished split-thickness graft take, and no difference in scar elasticity at long-term follow-up ^[26].

NovoSorb BTM in 27 patients with 35 wounds across heterogeneous etiology (deep dermal and full-thickness burns, necrotizing fasciitis, free flap donor site) showed 100% integration in 33 wounds at the time of sealing membrane removal; partial graft loss in 7 wounds healed by secondary intention; in 2 cases re-epithelialization occurred without overlying split-skin graft ^[25]. BTM offers a safe and reliable reconstructive option in challenging wounds that would otherwise require more complex operations ^[25]. In a 25-patient intrapatient (paired-site) randomized controlled trial of an acellular dermal substitute versus standard of care in burns and reconstructions, graft take and wound healing were statistically lower or delayed in the dermal-matrix group versus STSG alone (P < 0.004), though at 12 months postsurgery, skin extension (P = 0.034) and elasticity (P = 0.036) were better in the dermal-matrix group, indicating enhanced scar maturation ^[2]. Final scar quality at 6 years was similar between dermal-matrix and STSG-alone arms, suggesting that dermal substitution accelerates short-term scar pliability without changing the long-term endpoint ^[2].

In pediatric reconstruction of finger wounds with exposed bone and/or tendon after electric burns, artificial dermis combined with thin intermediate-thickness autologous skin graft produced wound healing in 24.1 ± 2.7 days; total active motion of affected finger joints averaged 177 ± 40° at 12 months; and functional assessment was good in 12 fingers, medium in 23, and poor in 3 ^[42]. The technique is an alternative surgical method that effectively repairs bone- and tendon-exposed wounds in pediatric finger electric burns ^[42].

Hand reconstruction

The hand is the most data-rich anatomic context for skin-substitute reconstruction because functional outcome and contracture prevention drive product selection. In the meta-analysis of 532 pediatric hand burn grafts, FTSG produced a statistically significant decrease in post-graft contracture (OR 0.35, P = 0.0001) and in later surgical releases (OR 0.06, P = 0.00001) compared with STSG, with better postoperative functional ability, though STSG was superior on scar appearance, color, and hair growth, and donor and recipient site complaints did not differ ^[12]. The clinical anchor is that for the high-mobility recipient bed of a pediatric hand, FTSG buys functional outcome at the cost of donor-site morbidity.

In the systematic review on pediatric volar palmar burn coverage, STSG yielded poorer functional outcomes than FTSG on combined range-of-motion evaluation across three studies, but no study has shown FTSG to be significantly superior to STSG to achieve good functional outcomes on all dimensions ^[34]. The conclusion was that either FTSG or STSG can be utilized with consideration of several influential factors, splinting and physiotherapy chief among them ^[34]. The systematic review of hand reconstruction techniques for postburn hand contractures across 7 observational studies and 1,310 patients reported functional and aesthetic outcomes for skin grafting and random or defined-vascularization flaps but found no studies on dermal substitutes meeting the inclusion criteria, significant risk of bias and indirectness in all studies, and no consensus on the superiority of a single reconstruction technique ^[4]. Meticulous preoperative planning and intensive rehabilitation are vital; a stepwise approach considering individual patient and contracture characteristics should be followed ^[4].

For deep dermal hand burns specifically, the comparison of allogeneic cryopreserved keratinocytes versus split-thickness skin grafts in 27 patients with mean TBSA 15% showed no statistically significant difference in Vancouver Scar Scale or DASH-score hand function on long-term follow-up, though the keratinocyte group trended toward higher VSS scores and impaired aesthetic results ^[35]. Allogeneic keratinocytes are recommended for deep dermal hand burns only in severely burned patients with a lack of donor sites; patients with unrestricted donor availability appear to benefit from STSG ^[35]. Limited availability, high cost, and the need for special skills render keratinocyte application outside specialist burn centers virtually impossible ^[35].

Contracture release

Burn scar contracture release is the most common reconstructive operation in burn surgery and the area where skin-substitute and flap evidence converges. In the multicenter randomized controlled trial of perforator-based interposition flaps versus full-thickness skin grafts for burn scar contracture release, mean scar surface area between 16 flaps and 14 FTSG differed significantly at 3 months (123% versus 87%; P < 0.001) and at 12 months (142% versus 92%; P < 0.001) ^[28]. POSAS observer score and color were superior with interposition flaps, leading the authors to conclude that perforator-based interposition flaps result in more effective scar contracture release than full-thickness skin grafts and should be preferred when possible ^[28].

Operative technique during contracture release matters. In the 160-patient pediatric RCT comparing tourniquet versus tumescent technique for flexion contracture release, the tumescent group had significantly greater graft take at day 14 (8.97 versus 7.26 cm²; P = 0.001), lower analgesic consumption (6.26 versus 9.41 mg; P ≤ 0.001), and significantly lower FLACC pain scores ^[43]. The tumescent technique is the preferred approach for postburn flexion contracture release in children ^[43]. For graft fixation after release, the comparative trial of three fixation methods (tie-over, skin stapler, cyanoacrylate glue) in adult contracture-release patients found mean fixation duration 34 minutes for tie-over, 7 minutes for stapler, and 12 minutes for cyanoacrylate; mean graft take 90.1%, 94.1%, and 93.8% respectively; cyanoacrylate had the lowest pain on dressing removal but at higher cost ^[45]. Skin stapler was the least time-consuming, affordable, and reliable method when graft take success was the primary endpoint ^[45]. Cyanoacrylate is the lowest-pain choice if cost permits.

For face and neck contracture, the expanded-flap technique combines tissue expansion of unburned chest, abdomen, or other regions with local advance, pedicled, and free transplantation ^[31]. The retrospective series after 4 to 15 months of expansion (total normal saline injection volume 238 to 2,000 mL) showed all flaps survived completely except for partial necrosis at the distal portion of 2 pedicled flaps; the expanded flaps effectively reconstructed scar contracture deformities in face and neck after extensive burns, restored function, and improved appearance ^[31]. For lateral cervical contracture specifically, the trapeze-flap plasty is the anatomically justified technique that allows maximum local-tissue use and ensures full contracture elimination ^[39]. For anterior neck resurfacing in patients with concomitant anterior thoracic burn sequelae, single circumflex scapular free flaps experience significantly greater flap descent and neck-extension deficit than in patients with isolated anterior neck sequelae (median descent 8 cm versus 0 cm; P < 0.05), arguing for larger flaps or multiple flaps in this anatomic context ^[40].

Cultured cellular products and donor-site economy

In massive-burn reconstruction where donor reserve is limited, cultured cellular products move from optional to essential. ASCS combined with widely meshed autograft achieved noninferior 8-week closure (65% versus 58% control; P = 0.005) while using 27.4% less donor skin (P < 0.001) in the multicenter RCT, with similar long-term scarring outcomes and safety profiles ^[3]. ReCell compared with split-thickness skin grafting in deep partial-thickness burns produced a donor area approximately 40 times smaller than control with significantly faster donor-site healing, lower donor-site pain over 16 weeks, and similar pain and scar outcomes at the treatment site ^[36]. The clinical case for ASCS and ReCell in reconstruction is precisely that they reduce or replace the secondary wound that autograft creates.

Cultured epidermal autograft produced 83% engraftment and 90% overall survival in 40 patients with mean TBSA 56% in the multicenter retrospective review ^[15]. The earlier 82-patient RCT comparing ReCell against classical skin grafts for deep dermal burns showed both achieved adequate epidermal replacement, with skin grafting faster than ReCell (P < 0.05), but ReCell biopsy areas and postoperative pain were smaller than classic grafting (P < 0.05) and aesthetic and functional outcomes were similar ^[16]. ReCell is a feasible, simple, and safe technique that can open future applications in the management of large-burn patients through smaller harvested donor areas ^[16]. The systematic review of cultured cells in burn treatment across 14 studies including 8 RCTs found that tissue-engineered skin substitutes from cultured epidermal autografts to dermal regeneration templates seeded with cultured cells showed promising outcomes, with several substitutes exhibiting take rates comparable to STSG with improved scar quality, although standardization and robust trials with larger populations are still lacking ^[6].

Allograft and acellular allogeneic dermis in reconstruction

Cryopreserved allograft skin and acellular allogeneic dermis cover a different reconstructive niche: temporary biological cover during staged reconstruction, definitive cover in fragile-skin populations, and reconstructive replacement when autograft is impractical. In the 48-patient comparison of cryopreserved versus glycerol-preserved allograft for severe burns, cryopreserved allograft had a mortality rate of 25% versus 34.8% (P = 0.250) and length of stay of 39.2-45.9 days (P = 0.730; primary-source phrasing reads as either a between-arm comparison or a cohort range, and the abstract is genuinely ambiguous on this point); the histological structural integrity was preserved with both methods, but cryopreserved was confirmed to be the more viable product (P < 0.05) ^[29]. The lower mortality rate associated with cryopreserved allograft cannot be totally ignored despite not reaching statistical significance, though the mechanism through which viable skin allografts improve mortality remains to be elucidated ^[29].

In burns over 40% TBSA second-degree, the 16-patient homograft cover group versus 13-patient twice-daily silver sulfadiazine group showed reduced hospital length of stay with homograft (P < 0.01), supporting early debridement and homograft cover as an alternative method to the conservative non-operative approach with topical antimicrobial therapy ^[37]. AlloDerm acellular dermis in pediatric pilot trial with 6 children with mean burn size 68.7% TBSA showed that 7-day epithelialization and Vancouver scar scores at study sites did not differ from autograft-only control sites despite the study autografts being substantially thinner (mean 0.0074 versus 0.0102 inch) ^[30]; the dermal substitute supported a thinner overlying autograft without compromising scar quality.

For the elderly burn population specifically, AlloDerm allowed more elderly burn patients to undergo operative wound closure, with significantly reduced length of stay versus the total elderly group managed with selective debridement and grafting; donor site healing time was significantly reduced (12 ± 1 days versus 18 ± 2 days); and graft take was similar to conventional autografting ^[38]. Three-month mortality remained poor regardless of operative approach, highlighting that AlloDerm is a tool to enable wound closure in patients whose donor skin is fragile, not a tool to change the overall mortality trajectory of severe geriatric burn ^[38].

Complications

The complication signature of skin-substitute reconstruction concentrates in three categories: take failure, infection, and graft-loss-driven contracture recurrence. Across the systematic review of 1,084 patients receiving dermal regenerative matrices, the overall complication rate was 13%, most commonly infection, graft loss, hematoma formation, and contracture ^[23]. In the postapproval Integra cohort, mean take rate was 76.2% with median 95%, indicating that partial integration is common but most grafts integrate well ^[19]. The mean take rate of overlying epidermal autograft on Integra in the same cohort was 87.7% with median 98%, reflecting that autograft on a well-integrated neodermis is reliable ^[19].

Infection is the next concern. In the postapproval Integra cohort, the incidence of invasive infection was 3.1% (95% CI 2.0 to 4.5%) and superficial infection 13.2% (95% CI 11.0 to 15.7%) ^[19]. Established wound infection is a contraindication to dermal substitute placement ^[1]. The clinical anchor is meticulous wound bed preparation, hemostasis, and close monitoring of the silicone layer for fluid collections, hematoma, or signs of cellulitis during the integration window. Negative-pressure wound therapy increases skin-graft take percentages over non-NPWT (with 80 mmHg subgroup superior to 125 mmHg) without increased adverse events in the systematic review and meta-analysis of 10 RCTs and 488 patients ^[5].

Donor-site morbidity is the rationale for cultured cellular products in reconstruction. ASCS combined with widely meshed autograft uses 27.4% less donor skin than standard meshed autograft; ReCell donor area is approximately 40 times smaller than a control split-thickness donor area, with less donor-site pain over 16 weeks ^[3][36]. Donor-site dressings impact this morbidity; in the platelet-rich-plasma comparison for STSG donor-site treatment, PRP and PRGF achieved 55% and 45% complete epithelialization at 8 days compared with 20% with hydrocolloid (statistical significance was reached on this comparison; P = 0.036), with no adverse effects and better pain control and scar quality observed in both PRP and PRGF groups ^[44]. PRP for STSG donor sites in the burn patient decreased time to epithelialization with better scar quality observed in both PRP and PRGF groups ^[44].

Recurrent contracture after release-and-graft is the long-term complication that drives flap-versus-graft decisions. In a single 30-patient multicenter RCT (n=16 perforator flap, n=14 FTSG), perforator-based interposition flaps maintained significantly greater scar surface area at 12 months (142% versus 92%; P < 0.001) than FTSG, which the trial authors interpreted as more effective contracture release with less recurrence over a year ^[28]. Hypertrophic scar at autograft sites is associated with increased pain and itch after major thermal burn injury, with linear regression showing significant association even after adjusting for age, sex, and ethnicity (β = 0.2, P = 0.033 for pain; β = 0.2, P = 0.019 for itch) ^[11]. Pre-burn chronic pain or itch is associated with pathological scarring 6 months following major thermal burn injury ^[11].

Special Considerations

Pediatric burn reconstruction

Pediatric reconstructive choices favor full-thickness skin grafting where contracture prevention matters most. In the meta-analysis of 532 pediatric hand burn grafts across 10 non-randomized trials, FTSG reduced post-graft contracture (OR 0.35, P = 0.0001) and later surgical releases (OR 0.06, P = 0.00001) compared with STSG, with better functional ability, though STSG produced better scar appearance, color, and hair growth, and donor or recipient site complaints did not differ ^[12]. Selection turns on the specific clinical priority for the individual patient. For pediatric volar palmar burns, either FTSG or STSG is acceptable with consideration of splinting and physiotherapy ^[34].

For pediatric burn reconstruction of face and neck, the extended lower trapezius myocutaneous flap is valuable: in 12 flaps performed in 11 children aged 1.5 to 7 years, all surgeries were successful with no intraoperative complications, only one case of mild tip necrosis postoperatively, no donor site complications, and good functional and cosmetic outcomes ^[32]. Tissue expansion of the deep layer of the lower trapezius muscle ensures the integrity of the vascular network between the lower trapezius muscle and the skin ^[32]. In the single-institution experience with 2,100 pediatric hand burns, 5.8% required skin grafting an average of 11.7 days after burn injury; surgical complications were minimal with 4.1% incomplete graft takes and 0.8% wound infection ^[13]. A multidisciplinary approach including standardized wound care led to spontaneous healing in approximately 95% of patients ^[13].

For pediatric finger reconstruction with exposed bone or tendon after electric burns, artificial dermis combined with autologous thin intermediate-thickness skin graft is an alternative surgical method that effectively repairs bone- and tendon-exposed wounds; mean wound healing time was 24.1 days, total active motion averaged 177° at 12 months, and functional assessment was good in 12 fingers, medium in 23, and poor in 3 ^[42].

Elderly burn reconstruction

The geriatric burn patient brings fragile skin, impaired healing, and reduced donor reserve to reconstruction. AlloDerm allows more elderly burn patients to undergo operative wound closure: in the elderly cohort, length of stay was significantly reduced compared with the total elderly group managed with selective debridement and grafting; donor site healing time was significantly reduced (12 ± 1 versus 18 ± 2 days); and graft take was similar to conventional autografting ^[38]. Functional outcome was improved in elderly patients who underwent skin grafting regardless of operative technique ^[38]. Three-month mortality remained poor regardless of operative skin grafting or technique, indicating that AlloDerm is the tool to enable surgical wound closure in this population, not a tool to alter overall survival ^[38].

Massive-burn reconstruction

Massive burns (TBSA 50% or greater) are the indication where cell-based and donor-site-economy products move from optional to essential in reconstruction as well as acute coverage. In the systematic review and meta-analysis of 30 studies and 1,369 patients with massive burns ≥50% TBSA across the most commonly employed wound-coverage techniques, mortality was highest with autografts (50%) and lowest with cell-based therapy (11%), length of stay was longest with cell-based therapy (91 days) and shortest with Meek micrografting (50 days), graft take was highest with autografts (96%) and lowest with cell-based therapy (72%), and average number of operations was highest with cell-based therapy (9) and lowest with Meek (4) ^[7]. The trade-off in massive burns is mortality versus operative count and length of stay. Each technique was associated with different advantages ^[7]. Interestingly, autografting (the option with the highest graft take rate) was also associated with the highest mortality, a paradox that highlights the need for prospective studies that directly compare techniques to establish whether a true superior option exists ^[7]. Meek micrografting in pediatric burns produced a significantly better take percentage than meshed grafts (84.25% versus 71.5%; P = 0.006), with better epithelialization and POSAS scar scores, longer operative time, and a learning-curve cost ^[14].

Reconstruction of complex anatomic units

For selected complex defects (exposed cartilage, mucosal continuity, joint mobility under hostile beds), flap reconstruction may be the right operation rather than dermal-substitute plus autograft. The burned ear remains a challenging procedure because of its location and thin integument; the cartilage framework will not recover or regenerate once injured, and the poor quality of adjacent skin and subcutaneous tissues makes the reconstruction of a burned ear an even more daunting procedure than congenital indications, with encouraging results shown in tissue engineering of skin and cartilage and 3D bioprinting ^[17]. For full-thickness electric burn wounds deep to tendon or even bone in fingers, foot microflap free transplantation achieves good appearance and function with better functional and sensory recovery in cases of nerve anastomosis ^[22]. Flap-specific decisions on lip-defect repair after facial destructive burns, free gracilis muscle flap with sural nerve transplantation in severe wrist electric burn, and broader perforator and free-tissue strategies are scoped to [[free-tissue-transfer-perforator-flaps-burn]].

Outcomes

The most robustly demonstrated outcomes across skin-substitute reconstruction are improved range of motion and improved scar quality compared with controls. Across the 1,084-patient systematic review of dermal regenerative matrices in burn patients (74% acute, 26% reconstruction), 95% of reconstructive patients with described range-of-motion changes showed significant improvement; Vancouver Scar Scale, used in eight studies, indicated significant improvement in scar quality with DRM ^[23]. Although variability in functional and cosmetic outcomes was observed, DRM demonstrated improvements in ROM and scar appearance without objective regression ^[23]. The xenogeneic ADM meta-analysis pooling 1,596 burn patients across 16 studies showed shorter wound healing time and lower VSS scores (SMD −2.50 and −3.10 respectively), with reduced ratios of scar hyperplasia, complications, skin grafting, and bacteria detection compared with controls ^[10]. Publication bias was present in wound healing time, VSS score, and complications outcomes ^[10].

For Integra in burned hands specifically, range of articular motion was complete in 15 of 17 hands, flexible skin coverage was achieved in 88% of hands, prehension strength was not statistically different from the contralateral non-burned hand, 16 hands had a painless evolution, the 400 Point Evaluation score averaged 92.8% (range 80 to 100), and 79% of patients returned to normal active working activities ^[21]. The Integra-MatriDerm comparative study showed both produced improvement in mobility and skin quality at 12-month follow-up, with the bilayer Integra showing the best performance in retraction rate, skin quality, and mobility recovery ^[9]. The Integra-versus-cellulose-sponge-versus-autograft prospective study found that final results for all treatments after 12 months demonstrated equal clinical appearance and histological findings, suggesting that dermal-template choice may matter less for long-term outcome than for the integration window ^[27]. The acellular-dermal-substitute-versus-STSG-alone trial in burns and reconstructions found that at 12 months postsurgery skin extension and elasticity were better in the dermal-matrix group (P = 0.034 and P = 0.036), other scar quality parameters did not differ, and final scar quality at 6 years was similar between treatment arms ^[2].

For perforator-based interposition flaps in contracture release, the mean scar surface area at 12 months was 142% with flaps versus 92% with FTSG (P < 0.001), with superior POSAS observer score and color ^[28]. The flap option produces a more effective scar contracture release than full-thickness skin grafts and should be preferred over FTSG when possible ^[28]. For ASCS in full-thickness skin defect coverage, 8-week closure was 65% with ASCS plus split-thickness skin graft versus 58% control, with 27.4% less donor skin required (P < 0.001) and similar long-term scarring outcomes ^[3]. For CEA in posterior burns, engraftment was 83% with overall survival 90% in 40 patients with mean TBSA 56% ^[15]. For ReCell in deep partial-thickness burns, ASCS-treated sites achieved comparable 4-week healing (98% versus 100% STSG control) with significantly smaller donor area, faster donor site healing, and lower donor site pain over 16 weeks ^[36].

Controversies and Evidence Gaps

No consensus on the superiority of any single hand-reconstruction technique

The systematic review of hand reconstruction techniques for postburn hand contractures across 7 observational studies and 1,310 patients identified significant risk of bias, indirectness, and imprecision in all studies, and no studies on dermal substitutes meeting the inclusion criteria ^[4]. Heterogeneity in outcome measures precluded meta-analysis ^[4]. No consensus remains on the superiority of a single reconstruction technique, and well-designed future studies utilizing reliable, validated contracture description methods and outcome assessment are imperative ^[4]. The current operative position is a stepwise approach considering individual patient and contracture characteristics and the limitations of each technique, supported by meticulous preoperative planning and intensive rehabilitation ^[4].

Cultured cell products: standardization gap

The cultured cellular evidence base is the largest single controversy in this space. The 2024 systematic review of 14 articles found that various tissue-engineered skin substitutes (from cultured epidermal autografts to dermal regeneration templates seeded with cultured cells) show promising outcomes, with several substitutes exhibiting take rates comparable to STSG with improved scar quality, but standardization of cultured skin substitutes and robust clinical trials with larger populations and appropriate comparators are still lacking ^[6]. The mortality advantage of cell-based therapy in massive burns is striking but the take-rate disadvantage is real, and the lack of standardized protocols across centers makes meta-analytic synthesis fragile ^[6][7].

Dermal-substitute-versus-STSG-alone in long-term scar outcome

The acellular-dermal-substitute-versus-standard-of-care RCT in burns and reconstructions showed that graft take and wound healing were lower or delayed in the dermal-matrix group versus STSG alone (P < 0.004), with skin extension and elasticity better in the dermal-matrix group at 12 months (P = 0.034 and P = 0.036), other scar quality parameters not different at 12 months, and final scar quality similar at 6 years ^[2]. The signal (better short-term elasticity, equivalent long-term scar quality) is honest about what dermal substitution does and does not do for the patient on long-term follow-up. The systematic review of dermal substitutes for deep dermal-to-full-thickness burns found that across 7 studies, three reported no significant difference in STSG take and four reported no significant difference in scar quality between dermal substitute and STSG alone ^[24]. Statistical pooling was not performed due to heterogeneity, and current RCTs are generally of small sample size with poor methodological reporting ^[24]. The collective signal is that dermal substitutes have a clear role in selected patients but do not uniformly improve scar quality across all burn-reconstruction populations.

Head-to-head among dermal templates

Comparative data on Integra versus MatriDerm versus AlloDerm versus xenogeneic ADM products are limited. The Integra-MatriDerm comparison in 12 patients per template for burn scar contracture release showed both produced improvement, with the bilayer Integra showing the best performance in retraction rate, skin quality, and mobility recovery ^[9]. The Integra-versus-cellulose-sponge-versus-autograft prospective study found equal clinical appearance and histological findings at 12 months despite different vascularization timelines ^[27]. The xenogeneic ADM meta-analysis pooled 16 studies and demonstrated publication bias in wound healing time, VSS score, and complications outcomes ^[10]. The clinical takeaway is that the dermal-template class is collectively effective in scar reconstruction, but ranking within the class is not yet supported by adequately powered head-to-head data.

Bioengineered skin substitutes: Integra safety in earlier evidence

The 2007 Cochrane-style systematic review of 20 RCTs on bioengineered skin substitutes for burns concluded that Biobrane, TransCyte, Dermagraft, Apligraf, autologous cultured skin, and allogeneic cultured skin were at least as safe as biological replacements or topical agents, but that the safety of Integra could not be determined and the efficacy of Integra could not be determined based on the available evidence at that time ^[46]. The postapproval multicenter Integra cohort of 216 patients reported 3.1% invasive infection and 76.2% mean take rate, supporting Integra as a safe and effective treatment modality under conditions of routine clinical use at burn centers ^[19]. Additional methodologically rigorous RCTs with long-term follow-up would still strengthen the evidence base for bioengineered skin substitutes generally ^[46].

References

[1] van den Bosch AS, Verwilligen RAF, Pijpe A, et al. "Indications for the use of dermal substitutes in patients with acute burns and in reconstructive surgery after burns: A systematic review." Wound Repair Regen 2025. PMID: 39727218. [2] Gardien KLM, Pijpe A, Brouwer KM, et al. "Short- and Long-term Outcomes of an Acellular Dermal Substitute versus Standard of Care in Burns and Reconstructions: A Phase I/II Intrapatient Randomized Controlled Trial." Adv Skin Wound Care 2023. PMID: 37729164. [3] Henry S, Mapula S, Grevious M, et al. "Maximizing wound coverage in full-thickness skin defects: A randomized-controlled trial of autologous skin cell suspension and widely meshed autograft versus standard autografting." J Trauma Acute Care Surg 2024. PMID: 38098145. [4] Vosinakis C, Ippoliti S, Samoladas E, et al. "Effectiveness of hand reconstruction techniques for the treatment of postburn contractures of the hand: A systematic review." Burns 2024. PMID: 39423713. [5] Jiang ZY, Yu XT, Liao XC, et al. "Negative-pressure wound therapy in skin grafts: A systematic review and meta-analysis of randomized controlled trials." Burns 2021. PMID: 33814213. [6] Simaey M, De Decker I, Vanlauwe F, et al. "The added value of cultured cells in burn treatment: A systematic review." Burns 2024. PMID: 39447287. [7] Haug V, Tapking C, Panayi AC, et al. "Outcome comparison of the most commonly employed wound coverage techniques in patients with massive burns ≥50% TBSA - A systematic review and meta-analysis." Burns 2024. PMID: 39322501. [8] Clayman MA, Clayman SM, Mozingo DW. "The use of collagen-glycosaminoglycan copolymer (Integra) for the repair of hypertrophic scars and keloids." J Burn Care Res 2006. PMID: 16679913. [9] Vana LPM, Battlehner CN, Ferreira MA, et al. "Comparative long-term study between two dermal regeneration templates for the reconstruction of burn scar contractures in humans: Clinical and histological results." Burns 2020. PMID: 31645293. [10] You AJ, Li WJ, Zhou JL, et al. "[Meta-analysis of the effects of xenogeneic acellular dermal matrix dressings in the treatment of wounds in burn patients]." Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi 2023. PMID: 36878527. [11] Mauck MC, Shupp JW, Williams F, et al. "Hypertrophic Scar Severity at Autograft Sites Is Associated With Increased Pain and Itch After Major Thermal Burn Injury." J Burn Care Res 2018. PMID: 29596686. [12] Alsaif A, Karam M, Hayre A, et al. "Full thickness skin graft versus split thickness skin graft in paediatric patients with hand burns: Systematic review and meta-analysis." Burns 2023. PMID: 36280545. [13] Nolan MM, Reppucci ML, Urban A, et al. "A Single Institution's Recent Experience With Pediatric Hand Burns." J Burn Care Res 2023. PMID: 36394415. [14] Noureldin MA, Said TA, Makeen K, et al. "Comparative study between skin micrografting (Meek technique) and meshed skin grafts in paediatric burns." Burns 2022. PMID: 35248428. [15] Homsombath B, Mullins RF, Brandigi C, et al. "Application and Management of Cultured Epidermal Autografts on Posterior Burns-A 5-Year, Multicenter, Retrospective Review of Outcomes." J Burn Care Res 2023. PMID: 35604809. [16] Gravante G, Di Fede MC, Araco A, et al. "A randomized trial comparing ReCell system of epidermal cells delivery versus classic skin grafts for the treatment of deep partial thickness burns." Burns 2007. PMID: 17904748. [17] Bos EJ, Doerga P, Breugem CC, et al. "The burned ear; possibilities and challenges in framework reconstruction and coverage." Burns 2016. PMID: 27268010. [19] Heimbach DM, Warden GD, Luterman A, et al. "Multicenter postapproval clinical trial of Integra dermal regeneration template for burn treatment." J Burn Care Rehabil 2003. PMID: 12543990. [21] Cuadra A, Correa G, Roa R, et al. "Functional results of burned hands treated with Integra®." J Plast Reconstr Aesthet Surg 2012. PMID: 22041337. [22] Xia CD, Xue JD, Xing PP, et al. "[Clinical effects of scalp flaps pedicled with superficial temporal artery parietal branch in repairing facial destructive burn wounds]." Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi 2023. PMID: 37899556. [23] Hicks KE, Huynh MN, Jeschke M, et al. "Dermal regenerative matrix use in burn patients: A systematic review." J Plast Reconstr Aesthet Surg 2019. PMID: 31492583. [24] Widjaja W, Tan J, Maitz PKM. "Efficacy of dermal substitute on deep dermal to full thickness burn injury: a systematic review." ANZ J Surg 2017. PMID: 28304144. [25] Li H, Lim P, Stanley E, et al. "Experience with NovoSorb® Biodegradable Temporising Matrix in reconstruction of complex wounds." ANZ J Surg 2021. PMID: 34085755. [26] Xia CD, Di HP, Xing PP, et al. "[Effects of free gracilis muscle flap combined with sural nerve transfer for reconstruction of digital flexion and sensory function of hand in patient with wrist electric burn]." Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi 2023. PMID: 37805718. [27] Lagus H, Sarlomo-Rikala M, Böhling T, et al. "Prospective study on burns treated with Integra®, a cellulose sponge and split thickness skin graft: comparative clinical and histological study--randomized controlled trial." Burns 2013. PMID: 23880091. [28] Stekelenburg CM, Jaspers MEH, Jongen SJM, et al. "Perforator-Based Interposition Flaps Perform Better Than Full-Thickness Grafts for the Release of Burn Scar Contractures: A Multicenter Randomized Controlled Trial." Plast Reconstr Surg 2017. PMID: 28121892. [29] Kua EH, Goh CQ, Ting Y, et al. "Comparing the use of glycerol preserved and cryopreserved allogenic skin for the treatment of severe burns: differences in clinical outcomes and in vitro tissue viability." Cell Tissue Bank 2012. PMID: 21484230. [30] Sheridan R, Choucair R, Donelan M, et al. "Acellular allodermis in burns surgery: 1-year results of a pilot trial." J Burn Care Rehabil 1998. PMID: 9848044. [31] Xue JD, Di HP, Liang Y, et al. "[Curative effects of foot microflap free transplantation in the repair of full-thickness electric burn wounds deep to tendon or even bone in fingers]." Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi 2023. PMID: 37805782. [32] Zheng XY, Guo X, Wang TL, et al. "Extended lower trapezius myocutaneous flap in burn scar reconstruction of the face and neck of children." Pediatr Surg Int 2011. PMID: 21822656. [33] Holmes JH. "A Brief History of RECELL® and Its Current Indications." J Burn Care Res 2023. PMID: 36567470. [34] Prasetyono TO, Sadikin PM, Saputra DK. "The use of split-thickness versus full-thickness skin graft to resurface volar aspect of pediatric burned hands: A systematic review." Burns 2015. PMID: 25720658. [35] Haslik W, Kamolz LP, Lumenta DB, et al. "The treatment of deep dermal hand burns: How do we achieve better results? Should we use allogeneic keratinocytes or skin grafts?." Burns 2010. PMID: 20022708. [36] Holmes Iv JH, Molnar JA, Carter JE, et al. "A Comparative Study of the ReCell® Device and Autologous Spit-Thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries." J Burn Care Res 2018. PMID: 29800234. [37] Naoum JJ, Roehl KR, Wolf SE, et al. "The use of homograft compared to topical antimicrobial therapy in the treatment of second-degree burns of more than 40% total body surface area." Burns 2004. PMID: 15302419. [38] Gore DC. "Utility of acellular allograft dermis in the care of elderly burn patients." J Surg Res 2005. PMID: 15836848. [39] Grishkevich VM, Grishkevich M. "Postburn Neck Lateral Contracture Anatomy and Treatment: A New Approach." J Burn Care Res 2015. PMID: 25501780. [40] Angrigiani C, Neligan P, Thrikutam N. "Anterior Neck Resurfacing Using a Single Free Flap: Comparison of Flap Descent in Patients With Burn Sequelae of the Neck/Chest and Patients With Burn Sequelae of Only the Neck." Ann Plast Surg 2019. PMID: 31464724. [41] Li R, Zheng Y, Fan X, et al. "Epidemiology and Predictors for Cervical Burn Scar Contractures: A Multicenter Cohort Study." J Craniofac Surg 2023. PMID: 37184463. [42] Kolokythas P, Aust MC, Vogt PM, et al. "[Dermal subsitute with the collagen-elastin matrix Matriderm in burn injuries: a comprehensive review]." Handchir Mikrochir Plast Chir 2008. PMID: 18629763. [43] Bashir MM, Sohail M, Wahab A, et al. "Outcomes of post burn flexion contracture release under tourniquet versus tumescent technique in children." Burns 2018. PMID: 29454711. [44] García-Sánchez JM, Mirabet Lis V, Ruiz-Valls A, et al. "Platelet rich plasma and plasma rich in growth factors for split-thickness skin graft donor site treatment in the burn patient setting: A randomized clinical trial." Burns 2022. PMID: 34952738. [45] Samal CC, Dash S, Agrawal K, et al. "Comparative evaluation of three methods of skin graft fixation for split thickness skin graft after release of post burn contracture of the neck." Burns 2019. PMID: 30482616. [46] Pham C, Greenwood J, Cleland H, et al. "Bioengineered skin substitutes for the management of burns: a systematic review." Burns 2007. PMID: 17825993.